A. Ross

Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques.

N. Davidson, M. Tallman, L. Akard, 1993, Blood.

Immunocytochemical analysis of tumor cells in pre- and post-culture peripheral blood progenitor cell collections from breast cancer patients.

M. Loudovaris, L. Schwartzberg, J. Bender, 1995, Experimental hematology.

Occult tumor contamination of hematopoietic stem-cell products does not affect clinical outcome of autologous transplantation in patients with metastatic breast cancer.

H. Lazarus, B. Cooper, T. Moss, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Bone marrow micrometastases in chemotherapy-responsive advanced breast cancer: effect of ex vivo purging with 4-hydroperoxycyclophosphamide.

N. Davidson, J. Davis, S. Noga, 1994, Cancer research.

Immunohistologic detection of prostate cancer pelvic lymph node micrometastases: correlation to preoperative serum prostate-specific antigen.

J. Moul, D. J. Lewis, D. Mcleod, 1994, Urology.

Immunocytochemical detection of tumor cells in bone marrow and peripheral blood stem cell collections from patients with ovarian cancer.

R. Meagher, T. Moss, D. Sweet, 1995, Bone marrow transplantation.

Early tumor cell dissemination in patients with clinically localized carcinoma of the prostate.

W. Ellis, R. Vessella, P. Lange, 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

A Novel Orthotopic Implantation Technique for Osteosarcoma Produces Spontaneous Metastases and Illustrates Dose-Dependent Efficacy of B7-H3-CAR T Cells

A. Davidoff, P. Nguyen, S. Gottschalk, 2021, Frontiers in Immunology.

Decrease in tumor cell contamination and progenitor cell yield in leukapheresis products after consecutive cycles of chemotherapy for breast cancer treatment.

L. Goldstein, A. Ho, S. Glück, 1997, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Use of a tumor-cell enrichment column for the enhanced detection of minimal residual disease in the BM or apheresis peripheral blood transplant products of breast-cancer patients.

H. W. Lee, S. Smith, S. Williams, 1999, Cytotherapy.

Absence of breast cancer cells in a single-day peripheral blood progenitor cell collection after priming with cyclophosphamide and granulocyte-macrophage colony-stimulating factor.

N. Davidson, J. Davis, A. Ross, 1995, Blood.